New agent overcomes drug resistance in HER2-positive breast cancer …

New agent overcomes drug resistance in HER2-positive breast cancer …

“This result is particularly exciting as it leads us to speculate the CDK4/6 inhibitors might not only help patients with metastatic breast cancer, but could potentially help in earlier stages of the disease where we aim to prevent recurrence of cancer

(Visited 2 times, 1 visits today)
2
Like
Save

Comments

Comments are disabled for this post.